947533-41-7 Usage
Uses
Used in Organic Synthesis:
4-Trifluoromethyl-pyridine-3-boronic acid is used as a building block for the synthesis of complex organic molecules, leveraging its ability to form carbon-carbon and carbon-heteroatom bonds. Its presence in cross-coupling reactions is instrumental in the construction of diverse molecular architectures.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-Trifluoromethyl-pyridine-3-boronic acid is utilized as a key intermediate in the synthesis of potential drug candidates. Its unique structural features and reactivity contribute to the development of new therapeutic agents with improved pharmacological properties.
Used in Chemical Transformations:
4-Trifluoromethyl-pyridine-3-boronic acid is employed in various chemical transformations due to its boronic acid functionality, which allows for the formation of stable complexes with Lewis acids. This enhances its utility in a range of chemical processes, broadening its applications in research and industry.
Overall, 4-Trifluoromethyl-pyridine-3-boronic acid is a versatile and important chemical compound with wide-ranging applications in both academic research and industrial applications, particularly in the fields of organic synthesis and pharmaceutical development.
Check Digit Verification of cas no
The CAS Registry Mumber 947533-41-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,4,7,5,3 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 947533-41:
(8*9)+(7*4)+(6*7)+(5*5)+(4*3)+(3*3)+(2*4)+(1*1)=197
197 % 10 = 7
So 947533-41-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H5BF3NO2/c8-6(9,10)4-1-2-11-3-5(4)7(12)13/h1-3,12-13H
947533-41-7Relevant articles and documents
2-ARYLIMIDAZO[1,2-B]PYRIDAZINE, 2-PHENYLIMIDAZO[1,2-A]PYRIDINE, AND 2-PHENYLIMIDAZO[1,2-A]PYRAZINE DERIVATIVES
-
Page/Page column 69, (2012/07/13)
Disclosed are compounds of formula (I): (Formula (I) where X, Y, X, A, R1; R2, and R3 are defined herein. Also disclosed are pharmaceutically acceptable salts of the compounds, compositions containing the compounds, and methods of using the compounds to treat, e.g., cancer.
